Melanoma Posts Page 2 on Medivizor
Navigation Menu

Melanoma Posts on Medivizor

“Your Life Depends on Your Own Advocacy”

“Your Life Depends on Your Own Advocacy”

Posted by on Sep 10, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

“Always trust your gut. Don’t leave your treatment in the hands of someone that you don’t trust or that does not seem like a team player. Yes, they are all smart—even brilliant—but read, read, read, and question them at every corner and challenge the standard of care. Exercise, healthy eating, learning the ropes of insurance, mediation/prayer...

Read More

Using cancer killing viruses as treatment for melanoma

Posted by on Sep 6, 2018 in Melanoma | 0 comments

In a nutshell This study wanted to analyse the current literature on using cancer killing viruses as a treatment for melanoma. The study found that there is only one virus that has been approved for use in treatment of melanoma, however there are others being developed, and current results are promising. Some background A new approach to treating...

Read More

Clinical Trials Today

Clinical Trials Today

Posted by on Aug 26, 2018 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Nocturia, Non-Hodgkin lymphoma, Overactive bladder, Parkinson's Disease, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 4 comments

Prior to the 20th century, most people lived about 47 years in the developed world because of infectious diseases. In 1940, the first use of penicillin to treat infectious diseases occurred and penicillin became available in 1945 to the general public. Science and research conducted throughout the 1950s, 60s, and 70s, created more antibiotics so that life...

Read More

White blood cells and survival from melanoma

Posted by on Aug 24, 2018 in Melanoma | 0 comments

In a nutshell This study looked at numbers of white blood cells in patients with melanoma, and how this was related to survival. The authors found that there was an association between the numbers of certain white blood cells and survival from melanoma, specifically, low ratios of neutrophils and platelets to lymphocytes resulted in lower overall...

Read More

Cancer Vaccines

Cancer Vaccines

Posted by on Aug 13, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 4 comments

When I think of vaccines, I think of the MMRV (measles, mumps, rubella and varicella) vaccines which help our bodies establish immunity against diseases that used to kill.  Now, there are vaccines being created for cancer. The rise of cancer vaccines According to Dr. Nora Disis, an oncologist and researcher in cancer vaccines at the University of...

Read More

Can S100B and lactate dehydrogenase (LDH) levels be used to predict survival in patients with melanoma?

Posted by on Aug 3, 2018 in Melanoma | 0 comments

In a nutshell This study investigated whether levels of S100B and lactate dehydrogenase (LDH) in patients with melanoma treated with immunotherapy has any relationship to survival. The study found that increased levels of S100B and LDH were associated with reduced survival in patients with melanoma treated with certain immunotherapies. Some background...

Read More

What factors can predict if melanoma patients respond to anti-PD-1 immunotherapy?

Posted by on Aug 2, 2018 in Melanoma | 0 comments

In a nutshell This study investigated whether there was a relationship between specific tumor characteristics (biomarkers) in melanoma patients and response to anti-PD-1 immunotherapy. This study found that patients with certain tumor characteristics had a better response to anti-PD-1 immunotherapy and experienced increased survival. Some background...

Read More

Does inflammation replacing tumor cells predict survival in patients with melanoma?

Posted by on Jul 23, 2018 in Melanoma | 0 comments

In a nutshell This study investigated if histological regression (HR – replacement of cancer tumor cells by inflammation) can be used to predict the course of disease (prognosis) in patients with stage III (advanced) melanoma. The study found that histological regression was associated with a better prognosis in patients with stage III...

Read More

Does Sentinel Lymph Node Biopsy Increase Survival in Patients with Thick Melanoma?

Posted by on Jul 16, 2018 in Melanoma | 0 comments

In a nutshell This study investigated whether Sentinel Lymph Node (SLN) biopsy increases survival in patients with thick melanoma. The study found that SLN biopsy was associated with an increase in disease free survival (DFS) in patients with melanoma. Some background Sentinel lymph node (SLN) biopsy is used to identify whether tumour has started...

Read More

Have survival rates improved for patients treated for Metastasis from Uveal Melanoma?

Posted by on Jul 16, 2018 in Melanoma | 0 comments

In a nutshell This study investigated if there has been an improvement in survival after treatment in patients with metastasis from uveal melanoma. The study found no significant improvement in survival rates in patients who were treated for metastasis from uveal melanoma. Some background Despite successful treatment of tumors in patients who are...

Read More